Oligonucleotide Synthesis Market to grow by USD 3.37 Billion from 2024-2028, driven by RNA-based therapeutics, Report on AI's impact on market trends - Technavio [Yahoo! Finance]
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Yahoo! Finance
to grow by USD 3.37 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 13.54% during the forecast period. Growing shift toward rna-based therapeutics is driving market growth, with a trend towards integration of ai and automation in oligonucleotide synthesis. However, regulatory issues associated with oligonucleotide therapeutics poses a challenge. Key market players include Agilent Technologies Inc., Ajinomoto Bio Pharma. , Alnylam Pharmaceuticals Inc., Amgen Inc., Ansa Biotechnologies, Bio Synthesis Inc, Biogen Inc., Biotage AB, Danaher Corp., Eurofins Scientific SE, General Electric Co., Ionis Pharmaceuticals Inc., Kaneka Corp., LGC Science Group Holdings Ltd., Merck KGaA, Mettler Toledo International Inc., QIAGEN NV, Sarepta Therapeutics Inc., Synbio Technologies, Syngene International Ltd., and Thermo Fisher Scientific Inc.. AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opport
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Agilent to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Agilent Technologies, Inc. (NYSE: A) had its price target raised by analysts at Citigroup Inc. to $165.00. They now have a "buy" rating on the stock.MarketBeat
- Genomics in Cancer Care: North American Market Growth Forecasts and Business Opportunities, 2024-2031 [Yahoo! Finance]Yahoo! Finance
- Preimplantation Genetic Testing Market to hit USD 1.7 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Agilent Technologies, Inc. (NYSE: A) had its price target lowered by analysts at Bank of America Co. from $153.00 to $150.00. They now have a "neutral" rating on the stock.MarketBeat
A
Earnings
- 11/25/24 - Beat
A
Sec Filings
- 12/20/24 - Form 10-K
- 12/13/24 - Form 8-K
- 12/3/24 - Form 4
- A's page on the SEC website